Show simple item record

dc.contributor.authorAndreyev, H J
dc.contributor.authorDavidson, Susan E
dc.contributor.authorGillespie, C
dc.contributor.authorAllum, W
dc.contributor.authorSwarbrick, E
dc.date.accessioned2012-05-28T09:29:06Zen
dc.date.available2012-05-28T09:29:06Zen
dc.date.issued2012-02en
dc.identifier.citationPractice guidance on the management of acute and chronic gastrointestinal problems arising as a result of treatment for cancer. 2012, 61 (2):179-92 Guten_GB
dc.identifier.issn1468-3288en
dc.identifier.pmid22057051en
dc.identifier.doi10.1136/gutjnl-2011-300563en
dc.identifier.urihttp://hdl.handle.net/10541/226158en
dc.description.abstractBACKGOUND: The number of patients with chronic gastrointestinal (GI) symptoms after cancer therapies which have a moderate or severe impact on quality of life is similar to the number diagnosed with inflammatory bowel disease annually. However, in contrast to patients with inflammatory bowel disease, most of these patients are not referred for gastroenterological assessment. Clinicians who do see these patients are often unaware of the benefits of targeted investigation (which differ from those required to exclude recurrent cancer), the range of available treatments and how the pathological processes underlying side effects of cancer treatment differ from those in benign GI disorders. This paper aims to help clinicians become aware of the problem and suggests ways in which the panoply of syndromes can be managed.
dc.language.isoenen
dc.rightsArchived with thanks to Guten_GB
dc.subject.meshAntineoplastic Agentsen
dc.subject.meshBiological Therapyen
dc.subject.meshGastrointestinal Diseasesen
dc.subject.meshHumansen
dc.subject.meshNeoplasmsen
dc.subject.meshRadiotherapyen
dc.subject.meshSurgical Procedures, Operativeen
dc.titlePractice guidance on the management of acute and chronic gastrointestinal problems arising as a result of treatment for cancer.en
dc.typeArticleen
dc.contributor.departmentPelvic Radiation Disease and GI Unit, Royal Marsden NHS Foundation Trust, London, UK.en_GB
dc.identifier.journalGuten_GB
refterms.dateFOA2020-04-21T09:53:57Z
html.description.abstractBACKGOUND: The number of patients with chronic gastrointestinal (GI) symptoms after cancer therapies which have a moderate or severe impact on quality of life is similar to the number diagnosed with inflammatory bowel disease annually. However, in contrast to patients with inflammatory bowel disease, most of these patients are not referred for gastroenterological assessment. Clinicians who do see these patients are often unaware of the benefits of targeted investigation (which differ from those required to exclude recurrent cancer), the range of available treatments and how the pathological processes underlying side effects of cancer treatment differ from those in benign GI disorders. This paper aims to help clinicians become aware of the problem and suggests ways in which the panoply of syndromes can be managed.


Files in this item

Thumbnail
Name:
231646.pdf
Size:
390.4Kb
Format:
PDF
Description:
From UNPAYWALL

This item appears in the following Collection(s)

Show simple item record